<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38943168</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence of Post-COVID conditions among Mexican COVID-19 survivors: a nationwide cross-sectional study.</ArticleTitle><Pagination><StartPage>1729</StartPage><MedlinePgn>1729</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1729</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-19274-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There are limited population-representative data that describe the potential burden of Post-COVID conditions (PCC) in Mexico. We estimated the prevalence of PCC overall and by sociodemographic characteristics among a representative sample of adults previously diagnosed with COVID-19 in Mexico. We additionally, characterized the PCC symptoms, and estimated the association between diagnosed type-2 diabetes and hypertension with PCC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used data from the 2021 National Health and Nutrition Survey in Mexico, a nationally and regionally representative survey, from August 1st to October 31st, 2021. Using the WHO definition, we estimated the prevalence of PCC by sociodemographics and prevalence of PCC symptoms. We fit multivariable log-binomial regression models to estimate the associations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of PCC was 37.0%. The most common persistent symptoms were fatigue (56.8%), myalgia or arthralgia (47.5%), respiratory distress and dyspnea (42.7%), headache (34.0%), and cough (25.7%). The prevalence was higher in older people, women, and individuals with low socioeconomic status. There was no significant association between hypertension and PCC or diabetes and PCC prevalence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">About one-third of the adult Mexican population who had COVID-19 in 2021 had Post-COVID conditions. Our population-based estimates can help assess potential priorities for PCC-related health services, which is critical in light of our weak health system and limited funding.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ram&#xed;rez-Toscano</LastName><ForeName>Yenisei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Population Health Research, National Institute of Public Health, Santa Mar&#xed;a Ahuacatitl&#xe1;n, Avenida Universidad 655, Cuernavaca, Morelos CP, 62100, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Ibarra</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Population Health Research, National Institute of Public Health, Santa Mar&#xed;a Ahuacatitl&#xe1;n, Avenida Universidad 655, Cuernavaca, Morelos CP, 62100, Mexico. leticia.torres@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carnalla</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Population Health Research, National Institute of Public Health, Santa Mar&#xed;a Ahuacatitl&#xe1;n, Avenida Universidad 655, Cuernavaca, Morelos CP, 62100, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basto-Abreu</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Population Health Research, National Institute of Public Health, Santa Mar&#xed;a Ahuacatitl&#xe1;n, Avenida Universidad 655, Cuernavaca, Morelos CP, 62100, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vida&#xf1;a-Perez</LastName><ForeName>D&#xe8;sir&#xe9;e</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health Promotion Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colchero</LastName><ForeName>M Arantxa</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bautista-Arredondo</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saydah</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Coronaviruses and Other Respiratory Viruses Division, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrientos-Guti&#xe9;rrez</LastName><ForeName>Tonatiuh</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Population Health Research, National Institute of Public Health, Santa Mar&#xed;a Ahuacatitl&#xe1;n, Avenida Universidad 655, Cuernavaca, Morelos CP, 62100, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="Y">Survivors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091569" MajorTopicYN="N">Sociodemographic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mexico</Keyword><Keyword MajorTopicYN="N">Population-based study</Keyword><Keyword MajorTopicYN="N">Post-COVID condition</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>29</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>29</Day><Hour>15</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>29</Day><Hour>0</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38943168</ArticleId><ArticleId IdType="pmc">PMC11212168</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-19274-3</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-19274-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long- term effects of COVID-19. 2022. https://www.nice.org.uk/guidance/ng188. Accessed 15 Jun 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Post-COVID Conditions: Information for Healthcare Providers. 2022. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html. Accessed 24 Apr 2023.</Citation></Reference><Reference><Citation>Office for National Statistics (ONS). Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023. Accessed 11 Apr 2023.</Citation></Reference><Reference><Citation>National Center for Health Statistics, U.S. Census Bureau. Household Pulse Survey, 2022&#x2013;2023. Long COVID. 2023. https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm. Accessed 18 May 2023.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022;226:1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw E, Yashadhana A, Hitch D. Long COVID: sustained and multiplied disadvantage. Med J Aust. 2022;216:222&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115005</ArticleId><ArticleId IdType="pubmed">35249215</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11:269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:657&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11:7314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Tene L, Bergroth T, Eisenberg A, David SSB, Chodick G. Risk factors, health outcomes, healthcare services utilization, and direct medical costs of patients with long COVID. Int J Infect Dis. 2023;128:3&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">36529373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Torres-Macho J, Velasco-Arribas M, Plaza-Canteli S, Arias-Naval&#xf3;n JA, Hern&#xe1;ndez-Barrera V, et al. Preexisting hypertension is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: a case-control study. J Hum Hypertens. 2022;36:582&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8853057</ArticleId><ArticleId IdType="pubmed">35173268</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Misra A. Post COVID-19 Syndrome (&#x201c;Long COVID&#x201d;) and Diabetes: Challenges in Diagnosis and Management. Diabetes Metab Syndr. 2021;15:102235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JL, Oviedo SA, Ali MK, Ofotokun I, Gander JC, Patel SA, et al. The bidirectional association between diabetes and long-COVID-19 - a systematic review. Diabetes Res Clin Pract. 2023;195:110202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="pubmed">36496030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, Sim MS, Viswanathan N, Samras N, et al. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort. J Gen Intern Med. 2022;37:1988&#x2013;1995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HG, Dagliati A, Shakeri Hossein Abad Z, Xiong X, Bonzel CL, Xia Z, et al. International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit Med. 2022;5:81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9242995</ArticleId><ArticleId IdType="pubmed">35768548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Saddik B, AlSwaidan N, AlAnazi A, Ramakrishnan RK, Alhazmi D, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PLoS ONE. 2021;16:e0260568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022;20:244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Nonato I, Hern&#xe1;ndez-Barrera L, Oviedo-Sol&#xed;s C, Ram&#xed;rez-Villalobos D, Hern&#xe1;ndez B, Barquera S. Epidemiolog&#xed;a de la hipertensi&#xf3;n arterial en adultos mexicanos: diagn&#xf3;stico, control y tendencias. Ensanut 2020. Salud Publica Mex. 2021;63:692&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">35099908</ArticleId></ArticleIdList></Reference><Reference><Citation>Basto-Abreu A, L&#xf3;pez-Olmedo N, Rojas-Mart&#xed;nez R, Aguilar-Salinas CA, de la Cruz-G&#xf3;ngora V, Rivera-Dommarco J, et al. Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020. Salud Publica Mex. 2021;63:725&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">35099912</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Mart&#xed;nez M, Barrientos-Guti&#xe9;rrez T, Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA, Gaona-Pineda EB, et al. Metodolog&#xed;a de la Encuesta Nacional de Salud y Nutrici&#xf3;n 2021. Salud Publica Mex. 2021;63:813&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">35099889</ArticleId></ArticleIdList></Reference><Reference><Citation>Encuesta Nacional de Salud y Nutrici&#xf3;n. https://ensanut.insp.mx/. Accessed 23 Aug 2023.</Citation></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbrouckef JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85:867&#x2013;872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2636253</ArticleId><ArticleId IdType="pubmed">18038077</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamah-Levy T, Romero-Mart&#xed;nez M, Barrientos-Guti&#xe9;rrez T, Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA, et al. Encuesta Nacional de Salud y Nutrici&#xf3;n 2021 sobre Covid-19. Resultados nacionales. 1st ed. Mexico: Instituto Nacional de Salud P&#xfa;blica; 2022.</Citation></Reference><Reference><Citation>Greenland S. Model-based Estimation of Relative Risks and Other Epidemiologic Measures in Studies of Common Outcomes and in Case-Control Studies. Am J Epidemiol. 2004;160:301&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">15286014</ArticleId></ArticleIdList></Reference><Reference><Citation>McNutt LA, Wu C, Xue X, Hafner JP. Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes. Am J Epidemiol. 2003;157:940&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pubmed">12746247</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2022;55:101762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Almas T, Malik J, Alsubai AK, Jawad Zaidi SM, Iqbal R, Khan K, et al. Post-acute COVID-19 syndrome and its prolonged effects: An updated systematic review. Ann Med Surg (Lond). 2022;80:103995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9197790</ArticleId><ArticleId IdType="pubmed">35721785</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur J Intern Med. 2021;92:55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Vida&#xf1;a-P&#xe9;rez D, L&#xf3;pez-Olmedo N, Gonz&#xe1;lez-Morales R, Shamah-Levy T, Barrientos-Guti&#xe9;rrez T. Prevalence of Covid-19 sequelae in the National Health and Nutrition Survey 2020. Salud Publica Mex. 2021;63:799&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">35099891</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses. 2022;14:2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Lunz Trujillo K, Safarpour A, Santillana M, Ognyanova K, Druckman J, et al. Association of Post-COVID-19 Condition Symptoms and Employment Status. JAMA Netw Open. 2023;6:E2256152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:233&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">15662207</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2023;44:695&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-Pe&#xf1;as C, Guijarro C, Torres-Macho J, Velasco-Arribas M, Plaza-Canteli S, Hern&#xf3;andez-Barrera V, et al. Diabetes and the Risk of Long-term Post-COVID Symptoms. Diabetes. 2021;70:2917&#x2013;2921.</Citation><ArticleIdList><ArticleId IdType="pubmed">34580087</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabnam S, Razieh C, Dambha-Miller H, Yates T, Gillies C, Chudasama Y V, et al. Socioeconomic inequalities of Long COVID: a retrospective population-based cohort study in the United Kingdom. J R Soc Med. 2023;116(8):263&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10469969</ArticleId><ArticleId IdType="pubmed">37164035</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira JC, Moreira TCL, de Ara&#xfa;jo AL, Imamura M, Damiano RF, Garcia ML, et al. Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome. J Glob Health. 2022;12:05029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9359428</ArticleId><ArticleId IdType="pubmed">35939273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukkahatai N, Rodney T, Ling C, Daniel B, Han HR. Long COVID in the context of social determinants of health. Front Public Health. 2023;11:1098443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10088562</ArticleId><ArticleId IdType="pubmed">37056649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>